{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Radiation+Treatment&page=2", "query": { "intervention": "Standard Radiation Treatment", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 1621, "total_pages": 163, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Radiation+Treatment&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Radiation+Treatment&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-30T12:55:53.339Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05169957", "title": "Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Melanoma, Ocular", "Melanoma, Cutaneous", "Metastatic Melanoma", "Melanoma, Mucosal", "Liver Metastases" ], "interventions": [ { "name": "Ipilimumab", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" }, { "name": "Stereotactic Body Radiation Therapy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2022-08-09", "completion_date": "2024-07-17", "has_results": false, "last_update_posted_date": "2024-11-05", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05169957" }, { "nct_id": "NCT04041141", "title": "Oral Stent Device for Radiation Treatments of Oral Cancers", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Tongue Tumor", "Tongue Cancer" ], "interventions": [ { "name": "CT Scan", "type": "DIAGNOSTIC_TEST" }, { "name": "Experimental Oral Stent Device", "type": "DEVICE" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DEVICE" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2019-09-25", "completion_date": "2021-02-03", "has_results": false, "last_update_posted_date": "2021-02-09", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04041141" }, { "nct_id": "NCT01618357", "title": "Pre-Operative Radiation and Veliparib for Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Radiation", "type": "RADIATION" }, { "name": "Lumpectomy/Mastectomy", "type": "PROCEDURE" }, { "name": "Veliparib", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "PROCEDURE", "DRUG" ], "sponsor": "Richard Zellars", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 19, "start_date": "2013-07-22", "completion_date": "2023-10-17", "has_results": false, "last_update_posted_date": "2024-05-22", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 6, "location_summary": "Avon, Indiana • Carmel, Indiana • Indianapolis, Indiana", "locations": [ { "city": "Avon", "state": "Indiana" }, { "city": "Carmel", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01618357" }, { "nct_id": "NCT00002812", "title": "Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "asparaginase", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "daunorubicin hydrochloride", "type": "DRUG" }, { "name": "dexamethasone", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "idarubicin", "type": "DRUG" }, { "name": "mercaptopurine", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "pegaspargase", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "thioguanine", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 2078, "start_date": "1996-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-08-26", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 32, "location_summary": "Long Beach, California • Los Angeles, California • Orange, California + 24 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002812" }, { "nct_id": "NCT01781819", "title": "(ARFI) Shear Velocity Imaging of the Kidneys in Pediatric Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Urine Reflux", "Kidney Damage" ], "interventions": [ { "name": "ARFI SVI Ultrasound Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "ALL", "summary": "Up to 18 Years" }, "enrollment_count": 0, "start_date": "2012-10", "completion_date": "2016-01", "has_results": false, "last_update_posted_date": "2015-06-01", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01781819" }, { "nct_id": "NCT06150417", "title": "MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer", "Malignant Neoplasm of Prostate", "Secondary Malignant Neoplasm of Prostate" ], "interventions": [ { "name": "Androgen deprivation therapy (ADT)", "type": "DRUG" }, { "name": "Androgen receptor signaling inhibitor (ARSI)", "type": "DRUG" }, { "name": "Local Therapy: Radical Prostatectomy (RP) or Radiotherapy (RT)", "type": "OTHER" }, { "name": "Metastasis directed radiotherapy (MDRT)", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "OTHER", "RADIATION" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 200, "start_date": "2024-07-01", "completion_date": "2028-12-01", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 3, "location_summary": "New York, New York • Cleveland, Ohio • Madison, Wisconsin", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06150417" }, { "nct_id": "NCT06899152", "title": "HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Liver Cancer", "Hepatocellular Carcinoma", "Hepatocellular Cancer", "Cholangiocarcinoma", "Liver Metastases" ], "interventions": [ { "name": "HepQuant DuO", "type": "DIAGNOSTIC_TEST" }, { "name": "Multiparametric MRI Scans", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2025-07-16", "completion_date": "2031-07", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06899152" }, { "nct_id": "NCT06035952", "title": "Study of 3D Scanning for Adolescent Scoliosis", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Scoliosis" ], "interventions": [ { "name": "3D topographical scan", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "NSite Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "10 Years to 18 Years" }, "enrollment_count": 70, "start_date": "2023-08-07", "completion_date": "2023-12-15", "has_results": false, "last_update_posted_date": "2023-09-13", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 2, "location_summary": "Palo Alto, California • Durham, North Carolina", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06035952" }, { "nct_id": "NCT06445738", "title": "Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Breast Cancer Female" ], "interventions": [ { "name": "Arm A: Radiotherapy Omission", "type": "RADIATION" }, { "name": "Arm B: Standard Treatment", "type": "OTHER" } ], "intervention_types": [ "RADIATION", "OTHER" ], "sponsor": "Breast Cancer Trials, Australia and New Zealand", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "FEMALE", "summary": "50 Years and older · Female only" }, "enrollment_count": 1400, "start_date": "2025-06-06", "completion_date": "2039-06", "has_results": false, "last_update_posted_date": "2026-01-15", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 2, "location_summary": "San Francisco, California • Houston, Texas", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06445738" }, { "nct_id": "NCT00689221", "title": "Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glioblastoma" ], "interventions": [ { "name": "Cilengitide", "type": "DRUG" }, { "name": "Temozolomide", "type": "DRUG" }, { "name": "Radiotherapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "EMD Serono", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 545, "start_date": "2008-09", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2014-11-04", "last_synced_at": "2026-09-30T12:55:53.339Z", "location_count": 1, "location_summary": "Rockland, Massachusetts", "locations": [ { "city": "Rockland", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00689221" } ] }